Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use GADOTERATE MEGLUMINE INJECTION safely and effectively. See full prescribing information for GADOTERATE MEGLUMINE INJECTION. GADOTERATE MEGLUMINE injection for intravenous useInitial U.S. Approval: 2013
Medication labelWhy this: Advisory · dailymed-prescription
Gadoterate Meglumine Injection is a gadolinium-based contrast agent indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues in adult and pediatric patients (including term neonates) to detect and visualize areas with disruption of the blood brain barrier (BBB) and/or abnormal vascularity.
- generic_name
- gadoterate meglumine
- product_names
- gadoterate meglumine
- ndc
- 65219-080, 65219-082, 65219-084, 65219-086, 65219-080-01, 65219-080-05, 65219-082-01, 65219-082-10, 65219-084-01, 65219-084-15, 65219-086-01, 65219-086-20
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en